Evidence map›Paper›PMID 28074045›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2017

High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-κB Predicts Poor Prognosis in Cervical Cancer.

Zhiwang Song, Xia Zhang, Xiaojuan Ye, Chan Feng, Guang Yang, Yonglin Lu, Yun Lin, Chunyan Dong

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cell Trafficking at the Intersection of the Tumor-Immune Compartments.Annual review of biomedical engineering · 2022
    Review
  5. Review
  6. Article
  7. Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhiwang SongBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Xia ZhangBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Xiaojuan YeBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Chan FengBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Guang YangBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Yonglin LuBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Yun LinBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Chunyan DongBreast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai, China (mainland).
Shanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND SDF-1 and NF-κB are associated with the prognosis of a wide range of cancers, but their value in cervical cancer remains controversial. The aim of this study was to investigate the expression of SDF-1and NF-κB in cervical cancer and their significance in clinical prognosis. MATERIAL AND METHODS The expression of SDF-1and NF-κB in 105 formalin-fixed, paraffin-embedded cervical cancer tissues and the adjacent tissues was examined by immunohistochemistry (IHC). The results were semi-quantitatively scored and analyzed by chi-square test. The overall survival times (OS) were collected by follow-up and analyzed by Kaplan-Meier analysis. RESULTS The expression level of both SDF-1and NF-κB in cervical cancer are higher than that in the adjacent tissues (P<0.05). SDF-1 expression are correlated with tumor size and FIGO histology grade (P<0.05). NF-κB expression are correlated with tumor size and FIGO histology grade, and lymph node metastasis (LNM) status (P<0.05). The patients with a positive expression of SDF-1or NF-κB tended to have much shorter survival time than patients with negative expression. In addition, multivariate Cox regression analysis demonstrated that SDF-1 expression and lymph node metastasis are independent predictors of the OS in cervical cancer patients. CONCLUSIONS The expression of SDF-1 is significantly associated with tumor size and FIGO histology grade. The expression of NF-κB is significantly associated with tumor size, FIGO histology grade, and lymph node metastasis. The positive SDF-1or NF-κB expression is significantly correlated with poor prognosis. These may be valuable biomarkers for the prognosis and the potential therapeutic targets of cervical cancer.

Indexed as

Chemokine CXCL12FemaleHumansImmunohistochemistryKaplan-Meier EstimateMiddle AgedNF-kappa BPrognosisUterine Cervical NeoplasmsChemokine CXCL12CXCL12 protein, humanNF-kappa B

Identifiers

PMID28074045
PMCPMC5244828
OpenAlexW2576601463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.